Skip to main content
. 2019 Apr 9;11(4):e4411. doi: 10.7759/cureus.4411

Table 6. The example of a score based decision approach in a chronic myeloid leukemia patient after the acute toxic imatinib-induced liver injury (imatinib withdrawal).

N/A- not applicable

Factors Imatinib restart*
The grade of hepatotoxicity reaction  
I grade  
II grade  
III grade  
IV grade / the presence of the liver transplantation or imatinib-induced liver cirrhosis caused by drug interaction or viral hepatitis reactivation 0
The presence of EMR to the imatinib therapy defined as three-month BCR-ABL1IS ≤10%:    
Yes  
No 0
The presence of EMR to the imatinib therapy defined as six-month BCR-ABL1IS <1% (if applicable****): N/A
Yes  
No  
The presence of the offender concomitant drug probably caused drug interaction    
Yes  
No 0
The presence of the viral hepatitis reactivation identified by Polymerase Chain Reaction (PCR+)    
Yes  
No 0